{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T22:24:32Z","timestamp":1781130272009,"version":"3.54.1"},"reference-count":28,"publisher":"Public Library of Science (PLoS)","issue":"11","license":[{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Grants-in-Aid for Scientific Research, Japan Society for the Promotion of Science","award":["16K09155"],"award-info":[{"award-number":["16K09155"]}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0186588","type":"journal-article","created":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T20:41:46Z","timestamp":1509568906000},"page":"e0186588","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":22,"title":["Trend and treatment status of latent tuberculosis infection patients in Japan \u2013 Analysis of Japan TB Surveillance data"],"prefix":"10.1371","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2666-844X","authenticated-orcid":true,"given":"Lisa","family":"Kawatsu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiro","family":"Uchimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihiro","family":"Ohkado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2017,11,1]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1001\/jama.282.7.677","article-title":"Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence and mortality by country, WHO Global Surveillance and Monitoring Project","volume":"282","author":"C Dye","year":"1999","journal-title":"JAMA"},{"key":"ref2","article-title":"Guidelines on the management of latent tuberculosis infection","year":"2015"},{"key":"ref3","article-title":"Implementing the end TB strategy: the essentials","year":"2015"},{"key":"ref4","unstructured":"Kekkaku ni kansuru kansenshou yobo shishin (\u201cNational guideline on management of tuberculosis\u201d), No. 72, Notification of the Ministry of Health, Labour and Welfare, Japan, 2007, amended May 16, 2011."},{"key":"ref5","first-page":"497","article-title":"Treatment Guideline on LTBI","volume":"88","year":"2013","journal-title":"Kekkaku"},{"key":"ref6","first-page":"657","article-title":"Factors associated with changes in the number of latent tuberculosis infection notification in Japan: nationwide survey findings","volume":"90","author":"A Ohkado","year":"2015","journal-title":"Kekkaku"},{"key":"ref7","first-page":"507","article-title":"Senzai-sei kekkaku kansensho no chiryo seiseki to DOTS ni kansuru kento (Treatment outcome and DOT status of LTBI patients in Osaka City, Japan)","volume":"90","author":"K Kasai","year":"2015","journal-title":"Kekkaku"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1183\/13993003.01397-2015","article-title":"Monitoring latent tuberculosis infection diagnosis and management in the Netherlands","volume":"47","author":"C Erkens","year":"2016","journal-title":"Eur Respir J"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.jinf.2006.04.010","article-title":"Predictors of failure to complete treatment for tuberculosis infection","volume":"54","author":"E Parsyan","year":"2007","journal-title":"J Infect"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1378\/chest.09-0394","article-title":"Latent tuberculosis infection treatment acceptance and completion in the United States and Canada","volume":"137","author":"C Horsburgh","year":"2010","journal-title":"Chest"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1164\/ajrccm.162.6.2004022","article-title":"Outcomes of contact investigations of infectious tuberculosis patients","volume":"162","author":"S Marks","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.jinf.2006.04.010","article-title":"Predictors of failure to complete treatment for tuberculosis infection","volume":"54","author":"E Parsyan","year":"2007","journal-title":"J Infect"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1164\/rccm.200510-1667OC","article-title":"Predicting non-completion of treatment for latent tuberculosis infection: a prospective survey","volume":"174","author":"K Shieh","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"key":"ref14","first-page":"685","article-title":"Missed opportunities for prevention of tuberculosis among persons with HIV infection\u2013selected locations","volume":"49","year":"2000"},{"key":"ref15","first-page":"988","article-title":"Yield of tuberculin screening among injection drug users","volume":"8","author":"P Brassard","year":"2004","journal-title":"Int J Tuberc Lung Dis"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1093\/her\/cyg109","article-title":"Improving tuberculosis therapy completion after jail: translation of research to practice","volume":"20","author":"C White","year":"2005","journal-title":"Health Educ Res"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1164\/ajrccm.159.1.9807020","article-title":"A tuberculin screening and isoniazid preventive therapy program in an inner-city population","volume":"159","author":"N Bock","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1164\/rccm.200303-390OC","article-title":"Use of isoniazid for latent tuberculosis infection in a public health clinic","volume":"168","author":"A LoBue","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"key":"ref19","first-page":"775","article-title":"A randomized controlled trial of two treatment programes for homeless adults with latent tuberculosis infection","volume":"10","author":"M Nyamathi","year":"2006","journal-title":"Int J Tuberc Lung Dis"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/1471-2458-6-66","article-title":"The impact of smoking on adherence to treatment for latent tuberculosis infection","volume":"6","author":"M Lavigne","year":"2006","journal-title":"BMC Public Health"},{"key":"ref21","first-page":"1296","article-title":"Adverse events and treatment completion for latent tuberculosis in jail inmates and homeless persons","volume":"127","author":"N Lobato","year":"2005","journal-title":"Chest"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0196-6553(96)90056-5","article-title":"Tuberculosis in physicians: compliance with surveillance and treatment","volume":"24","author":"L Ramphal-Naley","year":"1996","journal-title":"A, J Infec Control"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1378\/chest.113.5.1184","article-title":"Effectiveness of a nosocomial tuberculosis control program at an urban teaching hospital","volume":"113","author":"P Lobue","year":"1993","journal-title":"Chest"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"188","DOI":"10.5588\/ijtld.16.0508","article-title":"Evaluation of tuberculosis contact investigation in Japan","volume":"21","author":"K Izumi","year":"2017","journal-title":"Int J Tuberc Lung Dis"},{"key":"ref25","article-title":"Kansensho-ho ni motozuku kekkaku no sesshoku sya kenko shindan no tebiki to sono kaisetu (Guideline on tuberculosis contact investigation, 5th edition)","author":"N Ishikawa","year":"2010"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1378\/chest.130.6.1712","article-title":"Enhancement of treatment completion for latent tuberculosis infection with 4 months of rifampicin","volume":"130","author":"A Lardizabal","year":"2006","journal-title":"Chest"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1164\/rccm.200404-478OC","article-title":"Treatment completion and costs of a randomized trial of rifampicin for 4 months versus isoniazid for 9 months","volume":"170","author":"D Menzies","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1001\/archinte.166.17.1863","article-title":"Improved adherence and less toxicity with rifampicin vs isoniazid for treatment of latent tuberculosis: a retrospective study","volume":"166","author":"R Page","year":"2006","journal-title":"Arch Intern Med"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0186588","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T15:32:02Z","timestamp":1589038322000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0186588"}},"subtitle":[],"editor":[{"given":"Petros","family":"Isaakidis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2017,11,1]]},"references-count":28,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2017,11,1]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0186588","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11,1]]}}}